Lighthouse Investment Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Lighthouse Investment Partners's BMY Position: Q2 2026 in Review
Lighthouse Investment Partners sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 42,245 shares — an estimated $2.56M sold.
Lighthouse Investment Partners first reported a position in BMY in Q1 2024 and held it in 4 quarters. The position peaked at $5.91M in Q1 2024. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Lighthouse Investment Partners reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
- Lighthouse Investment Partners sold 42,245 Bristol-Myers Squibb shares in Q2 2026, an estimated $2.56M.
- Lighthouse Investment Partners first reported a position in Bristol-Myers Squibb in Q1 2024 and held it in 4 quarters.
- Lighthouse Investment Partners's Bristol-Myers Squibb position peaked at $5.91M in Q1 2024.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Lighthouse Investment Partners's 13F filing for Q2 2026, filed 14 Aug 2026.